Search results
Results from the WOW.Com Content Network
Model – The marketing name for the GPU assigned by AMD/ATI. Note that ATI trademarks have been replaced by AMD trademarks starting with the Radeon HD 6000 series for desktop and AMD FirePro series for professional graphics. Codename – The internal engineering codename for the GPU. Launch – Date of release for the GPU.
The R420 GPU, developed by ATI Technologies, was the company's basis for its 3rd-generation DirectX 9.0/OpenGL 2.0-capable graphics cards.Used first on the Radeon X800, the R420 was produced on a 0.13 micrometer (130 nm) low-K photolithography process and used GDDR-3 memory.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
The R300 GPU, introduced in August 2002 and developed by ATI Technologies, is its third generation of GPU used in Radeon graphics cards. This GPU features 3D acceleration based upon Direct3D 9.0 and OpenGL 2.0, a major improvement in features and performance compared to the preceding R200 design. R300 was the first fully Direct3D 9-capable ...
ATI Radeon Xpress 1150 (ATI Radeon Xpress 200) May 23, 2006 Athlon 64, Athlon 64 FX, Athlon 64 X2, Sempron 110 1000 BI-DIRECTIONAL No Radeon X300 IGP, 400 MHz SB450, SB460, SB600, ULi M1575 A-Link Express II [a] RD480 ATI CrossFire Xpress 1600 (ATI Radeon Xpress 200 CrossFire Edition) September 27, 2005 Athlon 64, Athlon 64 FX, Athlon 64 X2 ...
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. [1] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. [1] [2] In these situations they decrease the need for blood transfusions. [2]
Related: 300 Trivia Questions and Answers to Jumpstart Your Fun Game Night What Is Today's Strands Hint for the Theme: "Board Certified"? Today's Strands game revolves around a craft that involves ...
They require the offending drug to be present in order to bind and lyse cells. [8] Drug-independent autoantibodies are a less common factor in DIIHA. Drug-independent autoantibodies are found in Drug-induced autoimmune hemolytic anemia because of beta-lactamase inhibitors and platinum-based chemotherapeutics.